Allergy

Latest News
August 15th 2025

Can Biomarkers Help Pinpoint the Right Treatment for Chronic Spontaneous Urticaria?

August 7th 2025

Chronic Spontaneous Urticaria Linked to Higher Patient Burden, Worse Quality of Life

July 30th 2025

Earlier Food Introduction Dramatically Reduces Peanut, Egg, Milk Allergy Rates in Infants

July 28th 2025

Patients With Chronic Spontaneous Urticaria Seek Better Treatment Beyond Current Options

July 25th 2025

AllergyAware E-Learning Training Program Boosts Anaphylaxis Preparedness in School Staff

Video Interviews
View All
May 29th 2025

Exploring the Interplay of Spring Allergies, Inflammation, and Mental Health: Gary Falcetano, PA-C, AE-C

August 20th 2024

Patient Education, Provider Education, and Overall Final Thoughts

August 13th 2024

Navigating New Frontiers: Bruton Tyrosine Kinase Inhibitors in Chronic Spontaneous Urticaria Treatment

August 13th 2024

The Evaluation of Dupilumab In Chronic Spontaneous Urticaria Treatment

August 6th 2024

Key Updates Needed in Chronic Spontaneous Urticaria Guidelines

August 6th 2024

Addressing Persistent Symptoms in Chronic Spontaneous Urticaria: Beyond IgE-Targeted Treatments

July 29th 2024

The Use of Systemic Corticosteroids In Chronic Spontaneous Urticaria Treatment

July 29th 2024

Approaches to Switching Between Antihistamines and Other Medications When Treating Patients with Chronic Spontaneous Urticaria 

July 29th 2024

Therapies Typically Used in the Firstline For Patients With Chronic Spontaneous Urticaria 

July 29th 2024

Healthcare Specialties Involved in Managing Patients With Chronic Spontaneous Urticaria 

More News

little girl who likes cow's milk | Image credit: Irina Schmidt - stock.adobe.com
July 16th 2025

Cow’s Milk Allergy in Breastfed Infants: What Clinicians and Families Need to Know

Skylar Jeremias
A new review explores the complexities of cow's milk allergy in breastfed infants, including symptoms, diagnosis challenges, and the impact of maternal diet.
Chronic rhinosinusitis with nasal polyps | Image Credit: Orawan - stock.adobe.com
July 15th 2025

Chronic Rhinosinusitis With Nasal Polyps and Asthma: Understanding the Connection and Treatment Gaps

Cameron Santoro
Chronic rhinosinusitis with nasal polyps increases the likelihood of developing coexisting conditions, such as asthma, underscoring the need for more effective, comprehensive treatments.
Urticaria. | Image Credit: teambdcx - stock.adobe.com
July 8th 2025

Personalizing Urticaria Treatment Through the Evolving Role of Biomarkers and Biopsies

Cameron Santoro
Current guidelines suggest limiting diagnostic testing for chronic spontaneous urticaria when no clear cause is suspected, though biomarkers and biopsies are emerging as tools to predict treatment response and personalize care.
Climate change and respiratory health. | Image Credit: Habibur - stock.adobe.com
June 30th 2025

Allergies and Asthma Prevalence Rise With Climate Change Extremes and Pollutants

Cameron Santoro
Increasing environmental events driven by climate change and human activity exacerbate allergy and asthma conditions, further compounded by exposure to persistent pollutants like per-and polyfluoroalkyl substances and microplastics.
Asthma lungs. | Image Credit: rashyn- stock.adobe.com
June 25th 2025

Reducing Oral Corticosteroid Dependence in Severe Asthma by Balancing Benefits, Burdens, Path to Safer Care

Cameron Santoro
Reducing the use of oral corticosteroids in patients with severe asthma is a pressing concern due to their associated adverse effects, health care costs, and impact on quality of life.
Chronic urticaria. | Image Credit: Cuoregentile - stock.adobe.com
June 16th 2025

Barzolvolimab Shows Long-Term Efficacy in Chronic Spontaneous Urticaria, Improving Patient Quality of Life

Cameron Santoro
New data shows that barzolvolimab offers sustained complete responses and significantly improved quality of life for patients with chronic spontaneous urticaria, with a favorable safety profile.
Gary Falcetano, PA-C, AE-C.
June 4th 2025

Proactively Protecting Mental and Physical Health During Peak Allergy Season With Gary Falcetano, PA-C, AE-C

Cameron Santoro Gary Falcetano, PA-C, AE-C
Gary Falcetano, PA-C, AE-C, explains that proactively managing seasonal allergies can significantly decrease the overall inflammatory burden, thereby improving both physical symptoms and potentially mitigating neuroinflammation's impact on mental well-being.
Gary Falcetano, PA-C, AE-C.
June 3rd 2025

Understanding the Mental Health Burden of Chronic Allergies and Early Diagnosis: Insights From Thermo Fisher's Gary Falcetano

Cameron Santoro Gary Falcetano, PA-C, AE-C
Gary Falcetano, PA-C, AE-C, features insights on how unaddressed chronic allergy symptoms contribute to mental health burdens and the critical role of early immunoglobulin E trigger identification in managing both physical and psychological wellbeing.
Peanut allergy. | Image Credit: Angela Schmidt - stock.adobe.com
June 3rd 2025

Peanut Oral Immunotherapy Extends Relief to Adults, Highlights Need for Future Research

Cameron Santoro
Adults with peanut allergy experienced effective treatment with peanut oral immunotherapy but future studies are necessary to confirm and characterize safety profiles among various subgroups.
Gary Falcetano, PA-C, AE-C
May 30th 2025

Chronic Allergic Inflammation's Impact on Brain Chemistry and Mood: Gary Falcetano, PA-C, AE-C

Cameron Santoro Gary Falcetano, PA-C, AE-C
Gary Falcetano, PA-C, AE-C, explained that chronic allergic inflammation can significantly affect brain chemistry and mood regulation.
Gut microbiota. | Image Credit: nobeastsofierce - stock.adobe.com
May 22nd 2025

Chronic Urticaria Linked to Specific Gut Bacteria and Metabolic Pathways

Cameron Santoro
A causal link between chronic spontaneous urticaria and gut microbiota, with metabolic pathways potentially acting as mediators, offer new avenues for research and clinical understanding.
Food allergy. | Image Credit: beats_ - stock.adobe.com
May 10th 2025

Pediatric Food Allergy Diagnosis Could Be Streamlined By New Scoring System

Cameron Santoro
A newly developed Naples Pediatric Food Allergy grading scale, incorporating clinical history and examination, shows promise in streamlining the diagnosis of food allergies in children, potentially reducing delays and health care burdens.
Allergic hives. | Image Credit: kanachaifoto - stock.adobe.com
May 6th 2025

Rilzabrutinib Reduces Itch and Hives in Antihistamine-Resistant Chronic Spontaneous Urticaria

Cameron Santoro
Patients with moderate to severe chronic spontaneous urticaria that were antihistamine-resistant to omalizumab experienced improvements with rilzabrutinib.
Asthma and Allergy Awareness. | Image Credit: Neelrong - stock.adobe.com
May 2nd 2025

National Asthma and Allergy Awareness Month: Economic Costs, Threats to Access, and the Impact of Policy Changes

Cameron Santoro
During National Asthma and Allergy Awareness Month, the high prevalence and costs of allergies and asthma in the US are evident, alongside disparities in treatment access and the potential impact of recent policy changes on environmental and public health efforts.
Dupilumab. | Image Credit: Semi - stock.adobe.com
Published: April 29th 2025 | Updated: April 29th 2025

Dupilumab Treatment for Patients With CSU: Insights From Jason Hawkes, MD, MS

Maddi Hebebrand
Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron Pharmaceuticals) in the management of chronic spontaneous urticaria (CSU), a condition with limited therapeutic options over the past decade.
Urticaria allergy. | Image Credit: Alex Pios - stock.adobe.com
April 23rd 2025

Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions

Cameron Santoro
Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
FDA Approved. | Image Credit: Tada Images - stock.adobe.com
April 18th 2025

FDA Greenlights Dupilumab for Chronic Spontaneous Urticaria, Marking First Approval in a Decade

Cameron Santoro
Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives and itching remain uncontrolled by antihistamines.
Skin hives. | Image Credit: Алексей Филатов - stock.adobe.com
April 16th 2025

Complete Responses Seen With Emerging Therapies for Chronic Spontaneous Urticaria

Cameron Santoro
There have been new developments in treatments for chronic spontaneous urticaria, with several options showing complete response in patients, particularly among those who are difficult to treat.
Hives, allergy. | Image Credit: Tanapat Lek,jew - stock.adobe.com
April 15th 2025

Significant Disease Burden and Management Issues in Chronic Spontaneous Urticaria

Cameron Santoro
Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for better management and understanding of the condition.
glass like gene strands | Image Credit: Сергей Шиманович - stock.adobe.com
April 5th 2025

Safety and Efficacy Updates for Asthma and Urticaria Therapies

Cameron Santoro
The long-term safety and efficacy of treatments for allergy and inflammatory conditions was highlighted at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Child with allergies outside with a tissue | Image credit: pingpao - stock.adobe.com
April 3rd 2025

Genetics and Environment Both Play a Role in Childhood Allergy Progression

Chelsie Derman
Genetics and environment both influence allergy risk, but environmental factors play a stronger role in the progression of allergic disease.
Child scratching neck on a yellow background | Image credit: Pixel-Shot - stock.adobe.com
April 2nd 2025

Oral Immunotherapy Can Play Key Role in Food Allergy Management in Preschool-Aged Patients

Gillian McGovern
Further research is needed to clarify the cost-effectiveness, long-term adherence, and psychosocial impacts of oral immunotherapy.
A panel of 4 experts on chronic spontaneous urticaria
July 12th 2024

Differential Diagnosis When Considering Chronic Spontaneous Urticaria 

Brian Keegan, MD, PhD Giselle Mosnaim, MD Stanley Goldstein, MD Anitha Shrikhande, MD, MPH
Stanley Goldstein, MD, discusses the differential diagnosis when considering CSU.
A panel of 4 experts on chronic spontaneous urticaria
July 12th 2024

The Epidemiology Associated With Chronic Spontaneous Urticaria 

Brian Keegan, MD, PhD Giselle Mosnaim, MD Stanley Goldstein, MD Anitha Shrikhande, MD, MPH
Giselle Mosnaim, MD, discusses the epidemiology that is associated with CSU.
A panel of 4 experts on chronic spontaneous urticaria
June 28th 2024

Hallmark Symptoms of Chronic Spontaneous Urticaria

Brian Keegan, MD, PhD Giselle Mosnaim, MD Stanley Goldstein, MD Anitha Shrikhande, MD, MPH
Experts on chronic spontaneous urticaria outline the hallmark symptoms most associated with the disease and how they fluctuate with time.
A panel of 4 experts on chronic spontaneous urticaria
June 28th 2024

The Pathophysiology of Chronic Spontaneous Urticaria

Brian Keegan, MD, PhD Giselle Mosnaim, MD Stanley Goldstein, MD Anitha Shrikhande, MD, MPH
A panel of experts describe the pathophysiology of chronic spontaneous urticaria.
Headshot of Gil Yosipovitch, MD
June 14th 2024

Newer Treatments for CSU Show Fast Response, Says Dr Gil Yosipovitch

AJMC Staff
Data on new treatments for chronic spontaneous urticaria (CSU) show significant symptom reduction very early during treatment.
Headshot of Gil Yosipovitch, MD
June 7th 2024

Dr Gil Yosipovitch: Biologics Have Changed the World of CSU Care

AJMC Staff
Given the lack of efficacy of antihistamines for most patients with chronic spontaneous urticaria (CSU), biologics have changed the entire world of CSU.
Headshot of Jonathan Bernstein, MD
May 24th 2024

Patients With CSU Need New Therapies, Says Dr Jonathan Bernstein

AJMC Staff
While there is treatment for chronic spontaneous urticaria (CSU), there remains a need for newer therapies, explained allergy specialist Jonathan Bernstein, MD.
Headshot of Jonathan Bernstein, MD
May 17th 2024

CSU Can Affect All Aspects of Patients’ Lives, Explained Dr Jonathan Bernstein

AJMC Staff
The chronic nature of the hives affecting patients with chronic spontaneous urticaria (CSU) can really affect all aspects of their lives, including sleep, daily activities, work, and interpersonal relationships.
12>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo